SHPH SHUTTLE PHARMACEUTICALS HOLDINGS INC Management Changes 8-K Filing 2025 - Resignations On May 9, 2025, Dr. Anatoly Dritschilo resigned as Chief Scientific Officer of Shuttle Pharmaceuticals, while the company held its Annual Meeting with over 66% shareholder participation, approving multiple proposals including a 1-for-3 to 1-for-100 reverse stock split and increasing shares for equity plans by 5 million.Get access to all SEC 8-K filings of the SHUTTLE PHARMACEUTICALS HOLDINGS INC